| Generic Name | Brand Name |
|---|---|
| Nonbiologic DMARDs | |
| Azathioprine | Azasan®; Imuran® |
| Cyclosporine A | Neoral®; Gengraf® |
| Penicillamine | Depen®; Cuprimine® |
| Leflunomide | Arava® |
| Methotrexate* | Methotrexate LPF® |
| Sulfasalazine* | Azulfidine®; Sulfazine® |
| Biologic DMARDs | |
| Abatacept* | Orencia® |
| Adalimumab* | Humira® |
| Anakinra | Kineret® |
| Etanercept* | Enbrel® |
| Infliximab | Remicade® |
| Intravenous immunoglobulin (IVIG) | BayGam®; Carimune® NF; Flebogamma® 5% DIF; Gammagard® S/D; Gammagard® Liquid 10%; Gammar-P®; Gamunex® 10%; Iveegam EN®; Octagam® 5%; Panglobulin®; Polygam® S/D; Privigen® 10%;Vivaglobin® |
| Tocilizumab | Actemra® |
All of the medicines in this list have been studied on children with JIA. Those followed by an * have been approved by the United States Food and Drug Administration (FDA) for treating JIA. This list of DMARDs may not include newer medicines that are being studied and used for JIA. Ask your doctor about the names of other DMARDs that may be available to you.
From: DMARDs for Juvenile Idiopathic Arthritis
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.